| Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release S Mahmoud, M Gharagozloo, C Simard, D Gris Cells 8 (2), 184, 2019 | 535 | 2019 |
| A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis M Absinta, D Maric, M Gharagozloo, T Garton, MD Smith, J Jin, ... Nature 597 (7878), 709-714, 2021 | 374 | 2021 |
| Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation P Bhargava, MD Smith, L Mische, E Harrington, KC Fitzgerald, K Martin, ... The Journal of clinical investigation 130 (7), 3467-3482, 2020 | 138 | 2020 |
| Silymarin impacts on immune system as an immunomodulator: One key for many locks N Esmaeil, SB Anaraki, M Gharagozloo, B Moayedi International immunopharmacology 50, 194-201, 2017 | 129 | 2017 |
| Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-κB activity and IL-2 production M Gharagozloo, E Velardi, S Bruscoli, M Agostini, M Di Sante, V Donato, ... Pharmacological Research 61 (5), 405-409, 2010 | 120 | 2010 |
| Sardasht-Iran cohort study of chemical warfare victims: design and methods T Ghazanfari, S Faghihzadeh, H Aragizadeh, MR Soroush, R Yaraee, ... Archives of Iranian medicine 12 (1), 5-14, 2009 | 114 | 2009 |
| Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms A Jamshidian, V Shaygannejad, A Pourazar, SH Zarkesh-Esfahani, ... Journal of neuroimmunology 262 (1-2), 106-112, 2013 | 102 | 2013 |
| Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction M Gharagozloo, S Majewski, M Foldvari Nanomedicine: Nanotechnology, Biology and Medicine 11 (4), 1003-1018, 2015 | 100 | 2015 |
| Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from β-thalassemia major patients F Alidoost, M Gharagozloo, B Bagherpour, A Jafarian, SE Sajjadi, ... International immunopharmacology 6 (8), 1305-1310, 2006 | 98 | 2006 |
| The expression of Th1‐and Th2‐related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy N Kheshtchin, M Gharagozloo, A Andalib, A Ghahiri, MR Maracy, ... American Journal of Reproductive Immunology 64 (2), 104-112, 2010 | 96 | 2010 |
| NLR-dependent regulation of inflammation in multiple sclerosis M Gharagozloo, KV Gris, T Mahvelati, A Amrani, JR Lukens, D Gris Frontiers in immunology 8, 2012, 2018 | 90 | 2018 |
| Dust events, pulmonary diseases and immune system N Esmaeil, M Gharagozloo, A Rezaei, G Grunig American journal of clinical and experimental immunology 3 (1), 20, 2014 | 87 | 2014 |
| Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages N Gholijani, M Gharagozloo, S Farjadian, Z Amirghofran Journal of immunotoxicology 13 (2), 157-164, 2016 | 86 | 2016 |
| The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine M Gharagozloo, Z Khoshdel, Z Amirghofran European Journal of Pharmacology 589 (1-3), 1-7, 2008 | 83 | 2008 |
| Variations in T-helper 17 and regulatory T cells during the menstrual cycle in peripheral blood of women with recurrent spontaneous abortion N Sereshki, M Gharagozloo, V Ostadi, A Ghahiri, MA Roghaei, ... International journal of fertility & sterility 8 (1), 59, 2014 | 81 | 2014 |
| Double-faced cell-mediated immunity in β-thalassemia major: stimulated phenotype versus suppressed activity M Gharagozloo, M Karimi, Z Amirghofran Annals of hematology 88, 21-27, 2009 | 80 | 2009 |
| Combined therapy of silymarin and desferrioxamine in patients with β‐thalassemia major: a randomized double‐blind clinical trial M Gharagozloo, B Moayedi, M Zakerinia, M Hamidi, M Karimi, M Maracy, ... Fundamental & clinical pharmacology 23 (3), 359-365, 2009 | 73 | 2009 |
| A randomized double‐blind, placebo‐controlled study of therapeutic effects of silymarin in β‐thalassemia major patients receiving desferrioxamine B Moayedi, M Gharagozloo, N Esmaeil, MR Maracy, H Hoorfar, ... European journal of haematology 90 (3), 202-209, 2013 | 70 | 2013 |
| Modulation of cytokine production and transcription factors activities in human Jurkat T cells by thymol and carvacrol N Gholijani, M Gharagozloo, F Kalantar, A Ramezani, Z Amirghofran Advanced pharmaceutical bulletin 5 (Suppl 1), 653, 2015 | 61 | 2015 |
| Immunomodulatory effect of concentrated lime juice extract on activated human mononuclear cells M Gharagozloo, A Ghaderi Journal of Ethnopharmacology 77 (1), 85-90, 2001 | 59 | 2001 |
Denis GrisProfessor of Immunology University of Sherbrooke在 usherbrooke.ca 的电子邮件经过验证
